Stay informed with the latest litigation news. Explore now

IP Verse

Novartis competitive analysis

Latest publications and patents of Novartis New

Explore the latest publications and patents granted to Novartis, showcasing their recent innovations and technological advancements.

Last updated on: Sep 5, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Novartis

EP4601746
Aug 20, 2025Tricyclic Compounds And Their UsesPending
EP4559935
Aug 20, 2025Pharmaceutical Products And Stable Liquid Compositions Of Il-17 AntibodiesPending
EP4559934
Aug 20, 2025Pharmaceutical Products And Stable Liquid Compositions Of Il-17 AntibodiesPending
EP3558361
Aug 20, 2025Myostatin, Activin Or Activin Receptor Antagonists For Use In Treating Obesity And Related ConditionsGranted
EP4594306
Aug 6, 2025Synthesis Methods And Intermediates For The Production Of RemibrutinibPending
EP4552697
Aug 6, 2025Protein Kinase C Inhibitors And Methods Of Their UsePending
EP4556908
Jul 30, 2025Identifying Patient Response To S1P Receptor Modulator AdministrationPending
EP4587047
Jul 23, 2025Treatment Of Autoimmune Disorders Using Chimeric Antigen Receptor TherapyPending
EP4563150
Jul 23, 2025New Crystalline Forms Of N-(3-(2-(2-Hydroxyethoxy)-6-Morpholinopyridin-4-Yl)-4-Methvlphenyl)-2(Trifluoromethyl) Isonicotinamide As Raf Inhibitors For The Treatment Of CancerPending
EP4323062
Jul 23, 2025Heteroaryl Aminopropanol Derivatives As Inhibitors Of Lta4HGranted

Latest oppositions filed by Novartis

Explore patent oppositions filed by Novartis against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 11, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP2784084
Il-17 A/F Heterologous Polypeptides And Therapeutics Uses ThereofGENENTECHJul 24, 2019
EP2888626
Contact Lens With A Hydrophilic LayerOCULAR DYNAMICSJan 18, 2019
EP2794727
Ionic Silicone HydrogelsJOHNSON & JOHNSON VISION CAREOct 24, 2018
EP2705073
Macroinitiator Containing Hydrophobic SegmentJOHNSON & JOHNSON VISION CAREOct 10, 2018
EP2855545
Polymers And Nanogel Materials And Methods For Making And Using The SameJOHNSON & JOHNSON VISION CAREAug 1, 2018
EP1623269
Hydrogel Contact Lenses And Package Systems And Production Methods For SameCOOPERVISIONFeb 9, 2018

Latest patents of Novartis opposed by its competitors

Explore Novartis's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP4218732
Mar 26, 2025Tablets Comprising Eltrombopag Olamine1
EP3143995
Jan 15, 2025A Rapamycin Derivative For Treating Lung Cancer7
EP3397755
Nov 6, 2024Methods Of Making Chimeric Antigen Receptor -Expressing Cells1
EP4321157
Oct 23, 2024New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)18
EP3487881
Aug 21, 2024Methods Of Treating New-Onset Plaque Type Psoriasis Using Il-17 Antagonists7
EP3090730
Jul 3, 2024Novel Pharmaceutical Composition7
EP2705808
May 1, 2024Silicone Hydrogel Lenses With Water-Rich Surfaces1
EP3124018
Apr 24, 2024Oral Formulations Of Deferasirox2
EP3529360
Apr 17, 2024Methods For Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (Pcsk9) Protein Reduction5
EP3191120
Apr 10, 2024Use Of Il-17 Antagonists To Inhibit The Progression Of Structural Damage In Psoriatic Arthritis Patients3

Latest PTAB cases involving Novartis New

Discover the latest PTAB cases involving Novartis, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 11, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Novartis

IPR2023-01346Aug 28, 2023NOVARTIS PHARMACEUTICALSTHE REGENTS OF THE UNIVERSITY OF MICHIGANFinal Written Decision - Appealed
IPR2023-01347Aug 28, 2023NOVARTIS PHARMACEUTICALSTHE REGENTS OF THE UNIVERSITY OF MICHIGANTerminated-Adverse Judgment
IPR2023-01045Jun 30, 2023NOVARTIS GENE THERAPIESAVENTISTerminated-Settled
IPR2023-01044Jun 30, 2023NOVARTIS GENE THERAPIESGENZYMETerminated-Settled
IPR2023-00609Feb 22, 2023NOVARTIS GENE THERAPIESGENZYMEInstitution Denied
IPR2023-00608Feb 22, 2023NOVARTIS GENE THERAPIESGENZYMEInstitution Denied
IPR2022-00886Apr 20, 2022NOVARTIS PHARMACEUTICALSSHILPA PHARMAFinal Written Decision - Appealed
IPR2022-00853Apr 12, 2022MILTENYI BIOMEDICINENOVARTIS PHARMAInstitution Denied
IPR2021-00816Apr 16, 2021REGENERON PHARMACEUTICALSNOVARTIS PHARMAFinal Written Decision
IPR2020-01263Aug 7, 2020BIOCON PHARMANOVARTIS PHARMACEUTICALSInstitution Denied

Top competitors of Novartis

Top competitors of Novartis based on patent oppositions.